Tag Archives: after

Pfizer Japan drawn into valsartan recall after finding API from Mylan is tainted

The global recall of valsartan has now extended to Pfizer and to Japan, via Mylan and India. According to a translated copy of its announcement, Pfizer’s Tokyo-based Japanese subsidiary said it is recalling from the country five lots of its blood pressure combo drug Amubaro because its API contains impurities that are probable carcinogens. The recall began… Read More »

More people die after surgery worldwide than from HIV, TB, and malaria combined

Around the world, 4.2 million people die every year within 30 days of surgery, and this translates to the third leading cause of death worldwide, a new study reveals. Since 50 per cent of these deaths occur in low- and middle-income countries, where surgery is less accessible, it reveals the disproportionate burden of postoperative death globally.… Read More »